Marrone Bio Innovations Inc (MBII) Stock Price, Quote, News and Overview
NASDAQ:MBII - Nasdaq - US57165B1061 - Common Stock
MBII Quote, Performance and Key Statistics
0.7981
-0.2 (-20.19%)
The current stock price of MBII is 0.7981 null. In the past month the price decreased by -28.1%. In the past year, price decreased by -43.8%.
MBII Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CTVA | CORTEVA INC | 24.61 | 43.03B | ||
| NTR | NUTRIEN LTD | 15.03 | 25.83B | ||
| CF | CF INDUSTRIES HOLDINGS INC | 12.12 | 13.56B | ||
| MOS | MOSAIC CO/THE | 11.5 | 8.18B | ||
| ICL | ICL GROUP LTD | 15.43 | 7.96B | ||
| FMC | FMC CORP | 11.02 | 4.78B | ||
| SMG | SCOTTS MIRACLE-GRO CO | 21.59 | 3.47B | ||
| UAN | CVR PARTNERS LP | 13.84 | 842.85M | ||
| IPI | INTREPID POTASH INC | N/A | 335.45M | ||
| BIOX | BIOCERES CROP SOLUTIONS CORP | 151.67 | 285.33M | ||
| AVD | AMERICAN VANGUARD CORP | N/A | 152.01M | ||
| ENFY | ENLIGHTIFY INC | N/A | 18.49M |
Related stock screener links
About MBII
Company Profile
Marrone Bio Innovations, Inc. engages in the provision of biological-based solutions for agricultural crops, turf protection, seed treatment, plant health and waterway systems. The company is headquartered in Raleigh, North Carolina and currently employs 153 full-time employees. The company went IPO on 2013-08-02. The firm offers 18 products that include Emergen, Foramin, Foramin ST, Grandevo, Haven, Jet-Ag, Jet-Oxide, Majestene, Pacesetter, Regalia, Stargus, UBP, UBP ST, Venerate, Zelto, and others. Its pipeline consists of products in three categories: bioprotection, seed and soil health, and plant health. Its product categories include products, which are referred to as biopesticides, bioinsecticides, bionematicides, biofungicides, biostimulants and bionutrition. The firm's end markets are row crops, such as corn and soybeans; fruits and vegetables, such as tomatoes, leafy greens and cucurbits; trees, nuts and vines, such as almonds and grapes; and greenhouse production, such as ornamentals and medicinal plants.
Company Info
Marrone Bio Innovations Inc
7780-420 Brier Creek Parkway, Raleigh
Raleigh NORTH CAROLINA 95618 US
CEO: Kevin Helash
Employees: 153
Company Website: https://marronebio.com/
Phone: 15307502800.0
Marrone Bio Innovations Inc / MBII FAQ
What is the stock price of Marrone Bio Innovations Inc today?
The current stock price of MBII is 0.7981 null. The price decreased by -20.19% in the last trading session.
What is the ticker symbol for Marrone Bio Innovations Inc stock?
The exchange symbol of Marrone Bio Innovations Inc is MBII and it is listed on the Nasdaq exchange.
On which exchange is MBII stock listed?
MBII stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for Marrone Bio Innovations Inc stock?
10 analysts have analysed MBII and the average price target is 1.4 null. This implies a price increase of 75.73% is expected in the next year compared to the current price of 0.7981. Check the Marrone Bio Innovations Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Marrone Bio Innovations Inc worth?
Marrone Bio Innovations Inc (MBII) has a market capitalization of 145.56M null. This makes MBII a Micro Cap stock.
How many employees does Marrone Bio Innovations Inc have?
Marrone Bio Innovations Inc (MBII) currently has 153 employees.
What are the support and resistance levels for Marrone Bio Innovations Inc (MBII) stock?
Marrone Bio Innovations Inc (MBII) has a resistance level at 1.07. Check the full technical report for a detailed analysis of MBII support and resistance levels.
Is Marrone Bio Innovations Inc (MBII) expected to grow?
The Revenue of Marrone Bio Innovations Inc (MBII) is expected to grow by 29.1% in the next year. Check the estimates tab for more information on the MBII EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy Marrone Bio Innovations Inc (MBII) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MBII, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MBII, evaluating the profitability, health, valuation and growth aspects
- Marrone Bio Innovations Inc (MBII) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Marrone Bio Innovations Inc (MBII) Sales and EPS estimates to see what analysts future expectations are.
- Marrone Bio Innovations Inc (MBII) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Marrone Bio Innovations Inc (MBII) Insider and Institutional Ownership to learn about the owners and their transactions.
- Marrone Bio Innovations Inc (MBII) Stock Chart to make your own analysis
- Marrone Bio Innovations Inc (MBII) Latest news and press-releases to stay up to date.
Does Marrone Bio Innovations Inc (MBII) stock pay dividends?
MBII does not pay a dividend.
When does Marrone Bio Innovations Inc (MBII) report earnings?
Marrone Bio Innovations Inc (MBII) will report earnings on 2022-08-15, after the market close.
What is the Price/Earnings (PE) ratio of Marrone Bio Innovations Inc (MBII)?
Marrone Bio Innovations Inc (MBII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.12).
MBII Technical Analysis
MBII Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MBII. MBII may be in some trouble as it scores bad on both profitability and health.
MBII Financial Highlights
Over the last trailing twelve months MBII reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by 0% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -47.09% | ||
| ROA | -27.42% | ||
| ROE | N/A | ||
| Debt/Equity | 0.33 |
MBII Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to MBII. The Buy consensus is the average rating of analysts ratings from 10 analysts.
For the next year, analysts expect an EPS growth of -7.1% and a revenue growth 29.1% for MBII